Article
A novel polymorphism in the PAI-1 gene promoter enhances gene expression. A novel pro-thrombotic risk factor?
Thrombosis research - 1 Dec 2014
Liguori Renato, Quaranta Sandro, Di Fiore Rosanna, Elce Ausilia, Castaldo Giuseppe, Amato Felice
Abstract excerpt
INTRODUCTION: Plasminogen activator inhibitor-1 (PAI-1) is the major physiological inhibitor of tissue-type plasminogen activator in plasma and the most important regulator of the fibrinolytic pathway. The 4G/5G polymorphism (rs1799889) in the PAI-1 promoter is associated with altered PAI-1 transcription. We have identified a new 4G/5G allele, in which a T is inserted near the 4G tract or replaces a G in the 5G...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
